Pacira BioSciences (PCRX) Selling, General & Administrative (2010 - 2026)
Pacira BioSciences (PCRX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 304.00 Mn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 588.00 Mn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 5.21 Bn |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | 184.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 928.80 Mn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 318.50 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 381.00 Mn |
| 10 | Pacira BioSciences | 1.07 Bn | 863.16 Mn | 140.96 Mn | 93.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.94 Mn |
| Dec 31, 2025 | 101.61 Mn |
| Sep 30, 2025 | 91.80 Mn |
| Jun 30, 2025 | 88.58 Mn |
| Mar 31, 2025 | 86.78 Mn |
| Dec 31, 2024 | 79.61 Mn |
| Sep 30, 2024 | 74.33 Mn |
| Jun 30, 2024 | 68.13 Mn |
| Mar 31, 2024 | 72.03 Mn |
| Dec 31, 2023 | 65.80 Mn |
| Sep 30, 2023 | 67.95 Mn |
| Jun 30, 2023 | 64.85 Mn |
| Mar 31, 2023 | 70.84 Mn |
| Dec 31, 2022 | 63.97 Mn |
| Sep 30, 2022 | 61.28 Mn |
| Jun 30, 2022 | 65.00 Mn |
| Mar 31, 2022 | 64.26 Mn |
| Dec 31, 2021 | 52.15 Mn |
| Sep 30, 2021 | 47.86 Mn |
| Jun 30, 2021 | 50.81 Mn |